Q4 2020 Holdings
Filed 2021-02-16 | 8 holdings | $10.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $10.5M | 1,620,244 | 99.3% |
| Oric Pharmaceuticals, Inc. | COM | 06822P109 | $16.8K | 496,893 | 0.2% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $13.9K | 108,630 | 0.1% |
| Natera, Inc.(NTRA) | COM | 632307104 | $12.7K | 127,305 | 0.1% |
| FibroGen, Inc.(FGENEUR) | COM | 31572Q808 | $11.3K | 305,784 | 0.1% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $10.8K | 998,278 | 0.1% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $9.4K | 1,641,804 | 0.1% |
| Novavax, Inc.(NVAX) | COM | 670002401 | $558 | 5,000 | 0.0% |